Biotricity is trading 12.86% lower at $0.06, with no clear catalyst identified for the decline.
- The move extends recent volatility and a slide from $0.10 on September 15, 2026.
- No company-specific announcement, filing, earnings update, or other catalyst explaining the September 25 decline was identified; the news archive shows no newer relevant release around the trading date.
- Healthcare and major indexes are higher, weakening the case for a sector-wide or broad-market explanation.